IVD Contract Manufacturing Market Size to Reach USD 43.79 Billion by 2033 Due to Surging Demand for In-Vitro Diagnostic Products Globally

U.S. IVD Contract Manufacturing Market was Valued at USD 8.09 Billion in 2025E and is Expected to Reach USD 16.05 Billion by 2033 Owing to Advancements in Automation in the U.S.

Austin, Feb. 06, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The IVD Contract Manufacturing Market size was valued at USD 21.61 billion in 2025E and is expected to reach USD 43.79 billion by 2033, growing at a CAGR of 9.31% from 2026-2033. IVD Contract Manufacturing Market is growing due to increased demand for in vitro diagnostic products and the rising trend of outsourcing manufacturing to specialized manufacturers.

The U.S. IVD Contract Manufacturing Market size was valued at USD 8.09 billion in 2025E and is expected to reach USD 16.05 billion by 2033, growing at a CAGR of 9.01% from 2026-2033. Advancements in automation, quality standards, and rising prevalence of chronic and infectious diseases are further supporting market expansion.

Get a Sample Report of IVD Contract Manufacturing Market Forecast @ https://www.snsinsider.com/sample-request/9059

IVD Contract Manufacturing Market Size and Forecast

• Market Size in 2025E: USD 21.61 Billion
• Market Size by 2033: USD 43.79 Billion
• CAGR: 9.31% from 2026 to 2033
• Base Year: 2025E
• Forecast Period: 2026–2033
• Historical Data: 2022–2024

Rising Demand for Diagnostic Tests and Increasing Outsourcing by IVD Companies to propel Market Expansion Globally

The global growth in demand for diagnostic testing notably for infectious diseases, chronic disorders, and preventative screening has pushed IVD makers to rely more heavily on outsourced partners. Contract manufacturing helps organizations cut operational expenses, expedite product development, and shorten regulatory deadlines. With increased need to launch new test kits and instruments swiftly, outsourcing offers scalability, access to specialist technologies, and efficient production capabilities. This collaborative model enables IVD developers to focus on core capabilities, such as R&D and commercialization while delegating high-precision manufacturing to specialized partners, driving global market growth.

Major Players Analysis Listed in the IVD Contract Manufacturing Market Report

• Thermo Fisher Scientific
• Jabil Inc.
• Sanmina Corporation
• TE Connectivity Ltd.
• Celestica Inc.
• West Pharmaceutical Services Inc.
• Merck KGaA
• Savyon Diagnostics
• TCS Biosciences Ltd.
• Invetech Inc.
• Bio-Techne Corp.
• Nova Biomedical
• Cone Bioproducts
• Maxim Biomedical Inc.
• Avioq Inc.
• Meridian Bioscience Inc.
• Coris BioConcept
• Cenogenics Corporation
• KMC Systems Inc.
• Fujirebio

IVD Contract Manufacturing Market Segmentation Analysis

By Product

Reagents & Consumables segment dominated the IVD Contract Manufacturing Market with the highest revenue share of about 62% in 2025 due to their constant demand in diagnostic testing, high-volume clinical applications, and recurring replenishment needs. Software & Services segment is expected to grow at the fastest CAGR from 2026-2033 due to rising adoption of digital diagnostics, cloud-based data management, and laboratory automation.

By Service

Manufacturing Services segment dominated the IVD Contract Manufacturing Market with the highest revenue share of about 68% in 2025 due to strong outsourcing trends among diagnostic companies seeking scalable, cost-efficient production. Assay Development Services segment is expected to grow at the fastest CAGR from 2026-2033 due to increasing demand for customized biomarker-based tests, rapid disease screening solutions, and personalized medicine applications.

By Technology

Immunoassays segment dominated the IVD Contract Manufacturing Market with the highest revenue share of about 32% in 2025 due to their broad application across infectious diseases, oncology, autoimmune disorders, and chronic disease diagnostics. Molecular Diagnostics segment is expected to grow at the fastest CAGR from 2026-2033 driven by increasing adoption of PCR, next-generation sequencing, and genetic testing for early disease detection and precision medicine.

By End-Use

Medical Device Companies segment dominated the IVD Contract Manufacturing Market with the highest revenue share of about 78% in 2025 due to large-scale outsourcing by major diagnostic manufacturers. Others (Startups/New Entrants) segment is expected to grow at the fastest CAGR from 2026-2033 due to increasing outsourcing by research laboratories, biotech start-ups, and academic institutes.

IVD Contract Manufacturing Market Regional Insights

North America dominated the IVD Contract Manufacturing Market with a 43% share in 2025 due to the presence of prominent in vitro diagnostic manufacturers, modern healthcare infrastructure, and increasing use of outsourced manufacturing solutions.

Asia Pacific is predicted to grow at the quickest CAGR of around 11.36% from 2026–2033, driven by rising need for inexpensive diagnostic solutions, developing healthcare infrastructure, and increasing prevalence of chronic and infectious diseases.

For an In-Depth Strategic Briefing with Our Research Team, Connect Now @ https://www.snsinsider.com/request-analyst/9059

IVD Contract Manufacturing Market Recent Developments

• 2024, TCS Biosciences launched “TCS Rapid Path”, a CE-marked point-of-care immunoassay platform for infectious disease testing (including RSV, influenza, and SARS-CoV-2) that delivers lab-quality results in under 15 minutes using a single drop of whole blood.
• 2025, Invetech announced the launch of “Invetech Flex Cell”, a modular, GMP-compliant cell therapy manufacturing platform designed for decentralized production of CAR-T and regenerative medicines. The system supports closed, automated workflows for academic medical centers and biotech’s with limited cleanroom space.

Exclusive Sections of the Report (The USPs)

• CLIENT BASE & DEMAND CONCENTRATION METRICS – helps you assess market reach by analyzing the number of active IVD clients, indicating outsourcing penetration among diagnostics companies, startups, and global OEMs.
• REPEAT CLIENT RATIO & RETENTION STRENGTH – helps you evaluate long-term business stability by tracking repeat client ratios, reflecting contract stickiness, regulatory switching costs, and service reliability.
• AVERAGE ORDER VALUE PER CLIENT – helps you understand revenue scalability by measuring average order size and contract value, highlighting differences between high-volume OEM clients and smaller diagnostic innovators.
• CLIENT CONCENTRATION RISK INDEX – helps you identify revenue vulnerability by assessing dependence on top-tier clients, enabling better risk management and diversification strategies.
• NEW CLIENT ONBOARDING LEAD TIME – helps you gauge growth agility by analyzing time required for regulatory validation, tooling, and quality audits before production contracts commence.
• END-USE SEGMENT EXPOSURE – helps you evaluate demand resilience by mapping client distribution across molecular diagnostics, immunoassays, rapid tests, and point-of-care devices.

IVD Contract Manufacturing Market Report Scope

Purchase Single User PDF of IVD Contract Manufacturing Market Intelligence Report @ https://www.snsinsider.com/checkout/9059

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Data
Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.